Oral cancer development in patients with leukoplakia - clinicopathological factors affecting outcome

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Liu, Wei ^a   Shi, Lin Jun ^b   Wu, Lan ^b   Feng, Jin Qiu ^c   Yang, Xi ^a   Li, Jiang ^b   Zhou, Zeng Tong ^b   Zhang, Chen Ping ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shanghai Municipal Hospital for Oral Health   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE INTERVAL; DISEASE SEVERITY; DYSPLASIA; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CANCER; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR BIOPSY; AGE; DISEASE FREE SURVIVAL; MIDDLE AGED; MOUTH TUMOR; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84859723644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034773     Document Type: Article

References (32)

1. Warnakulasuriya S, (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45: 309-316.
2. Petersen PE, (2009) Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol 45: 454-460.
3. Ganly I, Patel S, Shah J, (2012) Early stage squamous cell cancer of the oral tongue- clinicopathologic features affecting outcome. Cancer 118: 101-111.
4. Neville BW, Day TA, (2002) Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195-215.
5. van der Waal I, (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45: 317-323.
6. Zini A, Czerninski R, Sgan-Cohen HD, (2010) Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med 39: 299-305.
7. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E, (2008) Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37: 127-133.
8. Mehanna HM, Rattay T, Smith J, McConkey CC, (2009) Treatment and follow-up of oral dysplasia- a systematic review and meta-analysis. Head Neck 31: 1600-1609.
9. Tilakaratne WM, Sherriff M, Morgan PR, Odell EW, (2011) Grading oral epithelial dysplasia: analysis of individual features. J Oral Pathol Med 40: 533-540.
10. Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, et al. (2011) Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med 40: 677-683.
11. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, et al. (2000) Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6: 1702-1710.
12. Holmstrup P, Vedtofte P, Reibel J, Stoltze K, (2007) Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med 6: 262-266.
13. Arduino PG, Surace A, Carbone M, Elia A, Massolini G, et al. (2009) Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. J Oral Pathol Med 38: 540-544.
14. Warnakulasuriya S, Johnson NW, van der Waal I, (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36: 575-580.
15. van der Waal I, Schepman KP, van der Meij EH, Smeele LE, (1997) Oral leukoplakia: a clinicopathological review. Oral Oncol 33: 291-301.
16. Napier SS, Speight PM, (2008) Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 37: 1-10.
17. Shiu MN, Chen TH, Chang SH, Hahn LJ, (2000) Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 2000 82: 1871-1874.
18. Ho PS, Chen PL, Warnakulasuriya S, Shieh TY, Chen YK, et al. (2009) Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer 9: 260.
19. Silverman S Jr, Gorsky M, Lozada F, (1984) Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53: 563-568.
20. Schepman KP, van der Meij EH, Smeele LE, van der Waal I, (1998) Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 34: 270-275.
21. Lind PO, (1987) Malignant transformation in oral leukoplakia. Scand J Dent Res 95: 449-55.
22. World Health Organization (1997) World Health Organization international histological classification of tumours. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I, eds. Histological typing of cancer and precancer of the oral mucosa Berlin Springer pp. 21-23.
23. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, et al. (2006) Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 42: 987-993.
24. Holmstrup P, Vedtofte P, Reibel J, Stoltze K, (2006) Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42: 461-474.
25. Ribeiro AS, Salles PR, da Silva TA, Mesquita RA, (2010) A review of the nonsurgical treatment of oral leukoplakia. Int J Dent 2010: 186018.
26. van der Waal I, (2010) Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 46: 423-425.
27. Warnakulasuriya S, (2011) Squamous cell carcinoma and precursor lesions: prevention. Periodontol 2000 57: 38-50.
28. Lodi GSA, Bez C, Demarosi F, Carrassi A, (2006) Interventions for treating oral leukoplakia. Cochrane Databases Syst Rev 4: CD001829.
29. Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Mehta FS, et al. (1989) An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 63: 2247-2252.
30. Jeong WJ, Paik JH, Cho SW, Sung MW, Kim KH, et al. (2011) Excisional biopsy for management of lateral tongue leukoplakia. J Oral Pathol Med doi:10.1111/j.1600-0714.2011.01106.x.
31. Liu W, Bao ZX, Shi LJ, Tang GY, Zhou ZT, (2011) Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases. Histopathology 59: 733-740.
32. Liu W, Shen ZY, Wang LJ, Hu YH, Shen XM, et al. (2011) Malignant potential of oral and labial chronic discoid lupus erythematosus: a clinicopathological study of 87 cases. Histopathology 59: 292-298.